Fredun Pharmaceuticals Ltd.
BSE: 539730
₹1,278.35
₹-34.95
(-2.66%)
As on 06-Aug-2026 11:31IST
Market cap
₹2,117 Cr
Revenue (TTM)
₹748 Cr
P/E Ratio
48.3
P/B Ratio
7.2
Div. Yield
0 %
Quality Score
5/10
Growth Score
7/10
Valuation Score
2/10
Momentum Score
6/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹44 Cr
-
ROE
16.1 %
-
ROCE
21.3 %
-
Industry P/E
41.23
-
EV/EBITDA
20.6
-
Debt to Equity
0.8
-
Book Value
₹169.4
-
EPS
₹67.1
-
Face value
10
-
Shares outstanding
16,538,070
10 Years Aggregate
CFO
₹-10.29 Cr
EBITDA
₹259.78 Cr
Net Profit
₹96.68 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Fredun Pharma
| 143.0 | 48.1 | 52.6 | 255.4 | 51.6 | 56.1 | -- |
|
BSE Healthcare
| 17.9 | 2.3 | 13.0 | 16.0 | 22.5 | 14.1 | 12.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Fredun Pharma
| 115.0 | -14.5 | -22.4 | 32.5 | 107.1 | 84.6 | -34.3 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Fredun Pharma
|
1,278.4 | 2,116.9 | 747.5 | 43.8 | 13.4 | 20.1 | 48.3 | 7.2 |
| 3,261.5 | 26,653.1 | 1,461.8 | 387.4 | 34.5 | 25.2 | 69 | 15.4 | |
| 823.7 | 16,185.0 | 7,784.0 | 688.5 | 10.6 | 14 | 23.3 | 2.8 | |
| 439.9 | 16,302.5 | 2,141.5 | 58.5 | 5.8 | 3.3 | 153.5 | 4.2 | |
| 845.7 | 20,932.6 | 5,632.3 | 662.4 | 17.2 | 14.3 | 31.6 | 4.3 | |
| 918.7 | 16,531.8 | 4,078.3 | 1,371.9 | 30.2 | 15.9 | 11.7 | 1.8 | |
| 1,542.9 | 17,661.9 | 1,543.3 | -48.6 | 3.6 | -0.6 | -- | 3.0 | |
| 210.2 | 28,051.5 | 9,205.3 | -371.8 | 1.7 | -3.8 | -- | 3.5 | |
| 1,556.6 | 25,981.9 | 1,754.0 | 246.7 | -- | 27.8 | 105.3 | 20.7 | |
| 1,997.0 | 32,489.5 | 3,373.0 | 199.0 | 12.6 | 4.3 | 152.5 | 6.6 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Fredun Pharma
Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable... alkaloids; Read more
-
Incorporated
1987
-
Chairman
Daulat Medhora
-
Managing Director
Fredun Medhora
-
Headquarters
Mumbai, Maharashtra
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for Fredun Pharma
What is the current share price of Fredun Pharmaceuticals Ltd Today?
The share price of Fredun Pharmaceuticals Ltd is ₹1,278.35 (BSE) as of 06-Aug-2026 11:31 IST. Fredun Pharmaceuticals Ltd has given a return of 51.62% in the last 3 years.
What is the current PB & PE ratio of Fredun Pharmaceuticals Ltd?
The P/E ratio of Fredun Pharmaceuticals Ltd is 48.31 times as on 06-Aug-2026, a 17 premium to its peers’ median range of 41.23 times.
The P/B ratio of Fredun Pharmaceuticals Ltd is 7.22 times as on 06-Aug-2026, a 70 premium to its peers’ median range of 4.24 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2026
|
28.05
|
3.46
|
|
2025
|
15.99
|
2.23
|
|
2024
|
21.57
|
2.81
|
|
2023
|
32.60
|
4.00
|
|
2022
|
64.04
|
5.98
|
What is the 52 Week High and Low of Fredun Pharmaceuticals Ltd?
The 52-week high and low of Fredun Pharmaceuticals Ltd are Rs 1,331.70 and Rs 338.73 as of 06-Aug-2026.
What is the market cap of Fredun Pharmaceuticals Ltd?
Fredun Pharmaceuticals Ltd has a market capitalisation of ₹ 2,117 Cr as on 06-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Fredun Pharmaceuticals Ltd?
Before investing in Fredun Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.